Tag - astrazeneca

 
 

ASTRAZENECA

Japan Times
ASIA PACIFIC
Jan 30, 2021
Vietnam OKs AstraZeneca vaccine and cuts short Communist Party congress
Vietnam approved its first vaccine for the new coronavirus and cut short a key ruling Communist Party meeting on Saturday as it battled its biggest flare-up yet of COVID-19, state media reported.
Japan Times
ASIA PACIFIC / Science & Health
Jan 28, 2021
Taiwan asks Germany to help obtain coronavirus vaccines
The request comes after Berlin asked for the island's assistance in easing a shortage of automobile semiconductor chips.
Japan Times
WORLD / FOCUS
Jan 28, 2021
Raging virus, few shots: How Brazil missed its chance to secure COVID-19 vaccines
Persistent delays have left Brazil's 210 million residents vulnerable to one of the worst coronavirus outbreaks on the planet.
Japan Times
WORLD
Jan 28, 2021
EU fails to sway AstraZeneca to tap U.K. supply for vaccines
The root of the dispute is Astra's decision to prioritize the U.K. over the EU following a Belgian production glitch, in what Brussels claims to be a breach of contractual commitments.
Japan Times
JAPAN / Science & Health / FOCUS
Jan 18, 2021
Japan scrambles to roll out vaccine, but how many people will get the shot?
Polls have shown recently that nearly 70% of Japanese are willing to get a coronavirus vaccine. But still, skepticism against vaccines is deeply rooted in the country.
Japan Times
ASIA PACIFIC
Jan 16, 2021
One of the world’s biggest vaccine campaigns starts in India
'These vaccines will help India win the battle against the virus,” Narendra Modi said, adding that Indians should get the shots and not pay heed to any anti-vaccine propaganda.
Japan Times
WORLD
Jan 4, 2021
U.K. touts progress against COVID-19 as it rolls out AstraZeneca vaccine
Britain began vaccinating its population on Monday with the COVID-19 shot developed by Oxford University and AstraZeneca, touting its position as the first Western country to roll out an inoculation program against the novel coronavirus.
Japan Times
ASIA PACIFIC
Jan 4, 2021
South Korea reviews AstraZeneca vaccine and expands ban on gatherings
South Korea is reviewing AstraZeneca's request for approval of its coronavirus vaccine, as it expands a ban on private gatherings of more than four people to the whole country with daily cases topping more than 1,000 in four days.
Japan Times
WORLD / Science & Health
Dec 30, 2020
Astra-Oxford coronavirus vaccine gets its first clearance with U.K. approval
AstraZeneca PLC and the University of Oxford's Covid-19 vaccine won U.K. clearance, marking the first approval worldwide for a shot that will be key to mass immunizations.
Japan Times
WORLD / Science & Health / FOCUS
Dec 27, 2020
How a British COVID-19 vaccine went from pole position to troubled start
A review of records and interviews with scientists and industry figures gives a detailed account of what went wrong with the Oxford-AstraZeneca study.
Japan Times
WORLD / Science & Health
Dec 23, 2020
How vaccine-makers are preparing for mutant coronavirus strains
Drugmakers have said they could reset the COVID-19 shot to counter a new strain within just six weeks.
Japan Times
WORLD / Science & Health
Dec 9, 2020
Testing times: More work needed on AstraZeneca/Oxford vaccine trials
A Lancet study gave few extra clues about why efficacy was 62% for trial participants given two full doses, but 90% for a smaller subgroup given a half, then a full dose.
Japan Times
WORLD / Science & Health
Dec 4, 2020
Fortune or foresight? AstraZeneca and Oxford's stories clash on COVID-19 vaccine
The two partners have given conflicting accounts of how they came upon the most effective dosing pattern for their COVID-19 vaccine.
Japan Times
WORLD / Science & Health
Nov 27, 2020
AstraZeneca considers extra global vaccine trial as questions mount
Many low- and middle-income countries are relying on the firm, which has pledged to sell its vaccine at cost during the pandemic.
Japan Times
WORLD / Science & Health
Nov 26, 2020
After admitting error, AstraZeneca faces hard questions on vaccine
Scientists said a series of irregularities and omissions in the way AstraZeneca initially disclosed the data have eroded their confidence in the reliability of the results.
Japan Times
WORLD / Science & Health / FOCUS
Nov 24, 2020
Decades of work, and half a dose of fortune, drove Oxford vaccine success
The Oxford vaccinologists were exhilarated on Monday when drugmaker AstraZeneca, with whom they developed the shot, announced that it could be around 90% effective.
Japan Times
WORLD / Science & Health
Oct 27, 2020
Oxford COVID-19 vaccine prompts immune response in adults, AstraZeneca says
The COVID-19 vaccine being developed by the University of Oxford produces a similar immune response in both older and younger adults, and adverse responses were lower among older people, British drug maker AstraZeneca PLC said on Monday.
Japan Times
JAPAN / Science & Health
Oct 3, 2020
AstraZeneca's Japanese COVID-19 vaccine trial back on, but U.S. still paused
The British drugmaker said the early-to-mid-stage trial for the vaccine against the coronavirus resumed in Japan after consultations with the national health regulator
Japan Times
WORLD / Science & Health
Sep 18, 2020
COVID-19 vaccine leaders make trial plans public in transparency push
The moves come amid increasing concern that the effort to develop a COVID-19 vaccine is becoming politicized.
Japan Times
COMMENTARY / World
Sep 11, 2020
Traders are getting smarter about the vaccine race
Investors watching the COVID-19 vaccine development process could be forgiven for thinking it's not so hard. The effort has moved extraordinarily quickly so far, and with few hiccups.

Longform

Rows of irises resemble a rice field at the Peter Walker-designed Toyota Municipal Museum of Art.
The 'outsiders' creating some of Japan's greenest spaces